BLOG

Cleveland

Lyme disease vaccine discontinued, but new ways to prevent it are coming: Health Matters

Valneva’s vaccine, VLA15, encourages the body’s immune system to make antibodies to defend against the bacteria that cause Lyme disease. The FDA gave VLA15 fast-track designation in 2017, and the vaccine is currently in Phase 2 clinical studies.